Zomedica Secures CE Mark for TRUVIEW Digital Microscopy, Expands Into European Market
Zomedica Secures CE Mark for TRUVIEW Digital Microscopy, Expands Into European Market
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced it has secured the CE Mark for its revolutionary TRUVIEW digital microscopy and telepathology platform. The CE Mark certification affirms the system's compliance with the stringent health, safety, and environmental standards required by the European Union, enabling Zomedica to commercialize the TRUVIEW microscope across the European Economic Area (EEA).
zomedica公司（纽交所：ZOM）（“Zomedica”或“公司”）是一家兽医健康公司，提供适用于马匹和伴侣动物的现场诊断和治疗产品。今天，该公司宣布已获得其革命性TRUVIEW数字显微镜和远程病理学平台的CE认证。CE认证证实该系统符合欧盟要求的严格健康、安全和环保标准，使Zomedica能够在欧洲经济区（EEA）推广TRUVIEW显微镜。
The TRUVIEW platform integrates advanced diagnostic features, including LiquiView liquid lens technology for superior imaging and the proprietary TRUprep automated slide preparation system. This all-in-one solution empowers veterinary professionals with advanced capabilities that enhance both diagnostic accuracy and efficiency.
TRUVIEW平台集成了先进的诊断功能，包括用于卓越成像的LiquiView液体镜头技术和专有的TRUprep自动载玻片准备系统。这一体化解决方案赋予兽医专业人士先进能力，提高了诊断准确性和效率。
